Brief: Bioretec Gets Marketing Authorization From FDA
10/09/2026 08:27
BRIEF-Bioretec Gets Marketing Authorization From FDA Sept 10 (Reuters) - Bioretec Oy BRETEC.HE:
HAS RECEIVED MARKETING AUTHORIZATION FROM FDA FOR ACTIVASCREW CANNULATED COM
Source text: ID:nWkrbBwzdQ
Further company coverage: BRETEC.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Bioretec Oy
See all newsBrief: Bioretec Initiates Change Negotiations
Brief: Bioretec Gets Marketing Authorization From FDA
Brief: Bioretec Receives FDA 510(K) Clearance For Its Activascrew Cannulated Com Bioabsorbable Compression Screw
Finland's Bioretec H1 revenue rises 12%, loss narrows
Brief: Bioretec Q2 Net Sales EUR 1.1 Million